Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerlach

Showing results (241-250 of 352) with videos related to

Pageof 36
Sort By:
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
European Journal of Clinical Investigation|May 7, 1999
Nitric oxide diffusion across membrane lungs protects platelets during simulated extracorporeal circulationD Keh, M Gerlach, I Kürer, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1993
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeW W Hoover, E H Gerlach, D J Hoban, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Retrospective statistical analysis of coagulation parameters after 250 liver transplantationsH Gerlach, K J Slama, W O Bechstein, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug responseL C Young, B G Campling, T Voskoglou-Nomikos, et al.
Pageof 36

Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Diagnostic Microbiology and Infectious Disease|November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolatesP C Fuchs, R N Jones, A L Barry, et al.
European Journal of Clinical Investigation|May 7, 1999
Nitric oxide diffusion across membrane lungs protects platelets during simulated extracorporeal circulationD Keh, M Gerlach, I Kürer, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersA L Barry, R N Jones, L W Ayers, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1993
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeW W Hoover, E H Gerlach, D J Hoban, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Retrospective statistical analysis of coagulation parameters after 250 liver transplantationsH Gerlach, K J Slama, W O Bechstein, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug responseL C Young, B G Campling, T Voskoglou-Nomikos, et al.
Pageof 36